Chemistry Reference
In-Depth Information
Bornet F, Meflah K, and Menanteau J (2002) Enhancement of gut immune functions by short-
chain fructooligosaccharides and reduction of colon cancer risk.
Biosci Microflora
21,
55-62.
Bouhnik Y, Flourie B, Riottot M, Bisetti N, and Gailing M (1996) Effects of fructo-oligo-
saccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon
carcinogenesis in healthy humans.
Nutr Cancer
26, 21-29.
Bouhnik Y, Flourié B, Pochart P, Durand M, and Rambaud JC (1997) Administration of trans-
galactooligosaccharides increases fecal bifidobacteria and modifies colonic fermenta-
tion metabolism in healthy humans.
J Nutr
, 444-448.
Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, Marteau P, Flourié B, Bornet
F, and Rambaud J (1999) Dose-related effect of short-chain fructo-oligosaccharides
administration on the colonic bifidobacteria in healthy humans.
J Nutr
129, 113-116.
Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Brouns F, and Bornet F (2004) The
capacity of non digestible carbohydrates to stimulate fecal bifidobacteria in healthy
humans: A double-blind, randomized, placebo-controlled, parallel-group, dose-response
relation study.
Am J Clin Nutr
6, 1658-1664.
Bouhnik Y, Raskine L, Simoneau G, Paineau D, and Bornet F (2006) The capacity of short-
chain fructo-oligosaccharides to stimulate faecal bifidobacteria: A dose-response rela-
tionship study in healthy humans.
Nutr J
5, 8.
Bouhnik Y, Neut C, Simoneau G, Guillemot F, Vicaut E, Raskine L, Paineau D, Brouns F,
and Bornet F. Is different doses of non digestible carbohydrate associated with a bifido-
genic effect? A double blind randomized placebo controlled study in healthy humans.
Submitted (a)
.
Bouhnik Y, Paineau D, Attar A, Andrieux C, and Bornet F. Influence of fructans chain length
on the capacity to stimulate bifidobacterial growth in humans: Comparison between
short-chain fructooligosaccharides and long chain inulin. Submitted (b).
Boutron-Rouault M, Marteau P, Lavergne-Slove A, Myara A, Gerhardt M, Franchisseur C,
Bornet F, and Group atES (2005) Effects of a 3-mo consumption of short-chain fructo-
oligosaccharides on parameters of colorectal carcinogenesis in patients with or without
small colorectal adenomas.
Nutr Cancer
53, 160-168.
Bunselmeyer B (2006) Probiotics and prebiotics for the prevention and treatment of atopic
eczema.
Hautarzt
57, 785-791.
Cani P, Joly E, Horsmans Y, and Delzenne N (2006) Oligofructose promotes satiety in healthy
humans: A study pilot.
Eur J Clin Nutr
60, 567-572.
Casellas F, Borruel N, Torrejon A, Varela E, Antolin M, Guarner F, and Malagelada JR (2007)
Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well
tolerated and associated with lowered faecal calprotectin.
Aliment Pharmacol Ther
25,
1061-1067.
Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, and Wilson I (2002) Activation
of the mucosal immune system in irritable bowel syndrome.
Gastroenterology
122,
1778-1783.
Cherbut C (2003) Etude sur les prébiotiques et fonctions gastro-intestinales: Revue des effets
et des perspectives.
Cahiers Nutrition Diététique
38, 346-354.
Cherbut C, Aube A, Blottière H, Pacaud P, Scarpignato C, and Galmiche J (1996)
In vitro
con-
tractile effects of short-chain fatty acids in the rat terminal ileum.
Gut
38, 53-58.
Cherbut C, Aube A, Blottière H, and Galmiche J (1997) Effects of short-chain fatty acids on
gastrointestinal motility.
Scand J Gastroenterol
Suppl. 222, 58-61.
